Both in Pharmaceuticals
Apnimed vs Sagimet Biosciences Inc. Series A
Over the past year APMD returned −41.3% and SGMT returned −10.9%; their daily moves had a correlation of 0.31.
APMD −41.3% SGMT −10.9%Growth of $1, one year, split-adjusted
| Metric | APMD | SGMT |
|---|---|---|
| Price | $15.40 | $9.69 |
| Market cap | $641.1M | $687.1M |
| Today | −6.10% | −2.32% |
| 1 month | −28.4% | +6.0% |
| 6 months | — | +22.7% |
| Year to date | — | +63.7% |
| 1 year | — | +19.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 73.7% |
| Short % of float | 10.1% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).